Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

The efficacy of ibrutinib in the treatment of Richter syndrome

Mazie Tsang, Tait D. Shanafelt, Timothy G. Call, Wei Ding, Asher Chanan-Khan, Jose F. Leis, Grzegorz S. Nowakowski, Deborah Bowen, Michael Conte, Susan M. Schwager, Susan L. Slager, Neil E. Kay, Curtis A. Hanson, Sameer A. Parikh

Blood (2015) 125 (10): 1676–1678.

https://doi.org/10.1182/blood-2014-12-610782

Published: 2015

Journal Articles

The AKT Inhibitor MK2206 In Combination With Rituximab and Bendamustine Is Tolerable and Active In Relapsed Or Refractory Chronic Lymphocytic Leukemia: Results From a Phase 1 Study (NCCTG N1087 Alliance)

Wei Ding, MD, PhD, Tait D Shanafelt, MD, Clive S. Zent, MD, Jose F. Leis, MD, PhD, Betsy R. LaPlant, Timothy G. Call, MD, Curtis A Hanson, MD, Charles Erlichman, MD, Thomas M. Habermann, MD, Craig Reeder, MD, Daniel Nikcevich, Deborah Bowen, CNP, Michael J. Conte, PA-C, Justin Boysen, Charla Secreto, Connie Lesnick, M.Sc, Renee C. Tschumper, Diane F. Jelinek, PhD, Neil E. Kay, MD

Blood (2013) 122 (21): 2882.

https://doi.org/10.1182/blood.V122.21.2882.2882

Published: 2013

Journal Articles

An Effective and Tolerable Chemoimmunotherapy Regimen For Relapsed/Refractory and Very-High Risk Chronic Lymphocytic Leukemia Combining Alemtuzumab With Pentostatin and Low Dose Rituximab

Clive S. Zent, MD, Betsy R LaPlant, MS, Wenting Wu, PhD, Timothy G. Call, MD, Deborah Bowen, CNP, Michael J. Conte, PA-C, George J. Weiner, MD, Thomas E Witzig, MD

Blood (2013) 122 (21): 1641.

https://doi.org/10.1182/blood.V122.21.1641.1641

Published: 2013

Journal Articles

Long-term repair of T-cell synapse activity in a phase II trial of chemoimmunotherapy followed by lenalidomide consolidation in previously untreated chronic lymphocytic leukemia (CLL)

Tait D. Shanafelt, Alan G. Ramsay, Clive S. Zent, Jose F. Leis, Han W. Tun, Timothy G. Call, Betsy LaPlant, Deborah Bowen, Adam Pettinger, Diane F. Jelinek, Curtis A. Hanson, Neil E. Kay

Blood (2013) 121 (20): 4137–4141.

https://doi.org/10.1182/blood-2012-12-470005

Published: 2013

Includes: Supplemental data

Journal Articles

Allosteric Akt Inhibitor MK2206 Synergizes with Bendamustine in Promoting the Apoptosis of Chronic Lymphocytic Leukemia Cells and Selectively Targets B-Cell Receptor Mediated Cytokine Production

Wei Ding, MD, PhD, Tait D. Shanafelt, MD, Connie Lesnick, M.Sc, Traci Sassoon, Charla Secreto, Charles Erlichman, MD, Jose Leis, MD, PhD, Timothy G. Call, MD, Deborah Bowen, CNP, Shaji K. Kumar, MD, Neil E. Kay, MD

Blood (2012) 120 (21): 3928.

https://doi.org/10.1182/blood.V120.21.3928.3928

Published: 2012

Journal Articles

Clinical Utility of PET/CT Scanning in Patients with Chronic Lymphocytic Leukemia

Michael J. Conte, PA-C, Deborah Bowen, CNP, Kari G. Rabe, MS, Susan Schwager, Susan L Slager, PhD, Clive S. Zent, MD

Blood (2012) 120 (21): 3903.

https://doi.org/10.1182/blood.V120.21.3903.3903

Published: 2012

Journal Articles

Analysis of Stem Cell Transplant Referral in a Cohort of Newly Diagnosed Chronic Lymphocytic Leukemia Patients

Wei Ding, MD, PhD, Kari G. Rabe, MS, Ruchi G. Sharma, Susan Schwager, Susan L Slager, PhD, William J Hogan, MBBCh, Saad J. Sirop, MD, Neil E. Kay, MD, Timothy G Call, MD, Clive S. Zent, MD, Deborah Bowen, CNP, Michael J. Conte, PA-C, Tait D. Shanafelt, MD

Blood (2012) 120 (21): 4252.

https://doi.org/10.1182/blood.V120.21.4252.4252

Published: 2012

Journal Articles

The Prevalence of Serious Infectious Complications in a Cohort of Non-Referred Patients with Newly Diagnosed Chronic Lymphocytic Leukemia (CLL) Compared to Controls: Results of a Cohort Study

Jonathan Moreira, MD, Kari Rabe, MS, James R Cerhan, MD, PhD, John Wilson, MD, Neil Kay, MD, Clive S. Zent, MD, Deborah Bowen, Jose F. Leis, MD, PhD, Susan L Slager, PhD, Susan Schwager, Randy F Wendt, Timothy G Call, MD, Curtis A. Hanson, MD, Tait D. Shanafelt, MD

Blood (2011) 118 (21): 4610.

https://doi.org/10.1182/blood.V118.21.4610.4610

Published: 2011

Journal Articles

Lenalidomide Consolidation Appears to Prolong Time to Retreatment After First-Line Chemoimmunotherapy for Patients with Previously Untreated CLL,

Tait D. Shanafelt, MD, Han Tun, MD, Curtis A. Hanson, MD, Clive S. Zent, MD, Jose F. Leis, MD, PhD, Timothy G Call, MD, Betsy R. LaPlant, Deborah Bowen, EmilyS S Pavey, Diane F. Jelinek, Ph.D., Neil Kay, MD

Blood (2011) 118 (21): 3899.

https://doi.org/10.1182/blood.V118.21.3899.3899

Published: 2011

Journal Articles

Alemtuzumab Use and Survival After Reduced Intensity Allogeneic Stem Cell Transplantation in High-Risk Chronic Lymphocytic Leukemia (CLL),

Wei Ding, MD, PhD, Tait D. Shanafelt, MD, Kari Rabe, MS, Timothy G. Call, MD, Clive S. Zent, MD, Neil Kay, MD, David James Inwards, MD, Deborah Bowen, Mark R. Litzow, MD, Susan L Slager, PhD, Susan Schwager, William J Hogan, MBBCh

Blood (2011) 118 (21): 4152.

https://doi.org/10.1182/blood.V118.21.4152.4152

Published: 2011

Journal Articles

Lendalidomide Consolidation After First-Line Chemoimmunotherapy for Patients with Previously Untreated CLL

Tait Shanafelt, MD, Han Tun, MD, Curtis Hanson, Clive S. Zent, MD, Jose Leis, Timothy Call, MD, Betsy LaPlant, Deborah Bowen, Kristina Laumann, Diane F. Jelinek, PhD, Neil E. Kay

Blood (2010) 116 (21): 1379.

https://doi.org/10.1182/blood.V116.21.1379.1379

Published: 2010

Journal Articles

Infectious Complications In a Prospective Cohort of Community Based Newly Diagnosed Patients with Chronic Lymphocytic Leukemia (CLL).

Jonathan Moreira, MD, Timothy Call, MD, Kari Rabe, Randy Wendt, Clive S. Zent, MD, Neil E. Kay, MD, Deborah Bowen, Jose Leis, MD, Susan Slager, PhD, Jon Wilson, MD, Tait Shanafelt, MD

Blood (2010) 116 (21): 4610.

https://doi.org/10.1182/blood.V116.21.4610.4610

Published: 2010

Journal Articles

Treatment of Patients with Autoimmune Cytopenia and Progressive CLL Using Rituximab, Cyclophosphamide, Vincristine, and Prednisone (R-CVP).

Clive S. Zent, MD, Deborah Bowen, Timothy G Call, MD, Tait D. Shanafelt, M.D., Neil E. Kay, MD, Susan L Slager, PhD, Susan Schwager, Kari Rabe, Megan Reinalda

Blood (2009) 114 (22): 4410.

https://doi.org/10.1182/blood.V114.22.4410.4410

Published: 2009

Journal Articles

Influence of Age at Diagnosis On Utility of Prognostic Testing in Patients with CLL.

Tait D. Shanafelt, M.D., Kari Rabe, Neil E. Kay, MD, Clive S. Zent, MD, Diane F. Jelinek, PhD, Susan Schwager, Deborah Bowen, Susan L Slager, PhD, Megan Reinalda, Curtis A. Hanson, MD, Timothy G Call, MD

Blood (2009) 114 (22): 2342.

https://doi.org/10.1182/blood.V114.22.2342.2342

Published: 2009

Journal Articles

B-Cell Count and Survival: Differentiating Chronic Lymphocytic Leukemia (CLL) from and Monoclonal B-Cell Lymphocytosis (MBL) Based on Clinical Outcome.

Tait Shanafelt, MD, Neil E. Kay, Gregory Jenkins, Timothy G. Call, Clive S. Zent, Diane F. Jelinek, Justin Boysen, Susan Schwager, Deborah Bowen, Liam Zakko, Susan L. Slager, Curtis A. Hanson

Blood (2008) 112 (11): 2062.

https://doi.org/10.1182/blood.V112.11.2062.2062

Published: 2008

Journal Articles

Treatment Free Survival of Patients with MBL and Early CLL: Follow-up of 405 Patients at Mayo Clinic.

Tait Shanafelt, MD, Neil E. Kay, Kari Rabe, Timothy G. Call, Clive S. Zent, Kami Maddocks, MD, Diane F. Jelinek, Justin Boysen, Deborah Bowen, Susan Schwager, Gregory Jenkins, Susan L. Slager, PhD, Curtis A. Hanson

Blood (2008) 112 (11): 2063.

https://doi.org/10.1182/blood.V112.11.2063.2063

Published: 2008

Journal Articles

The Physician-Patient Relationship Impacts Patient Quality of Life in Chronic Lymphocytic Leukemia: Results of an International Survey of 1482 Patients.

Tait D. Shanafelt, MD, Deborah Bowen, Chaya Venkat, D.Ed., Susan L. Slager, PhD, Clive S. Zent, MD, Neil E. Kay, MD, Megan Reinalda, Jeff A. Sloan, PhD, Timothy G. Call, MD

Blood (2007) 110 (11): 2060.

https://doi.org/10.1182/blood.V110.11.2060.2060

Published: 2007

Journal Articles

Molecular Prognostic Factors and Outcome among a Cohort of Patients with Monoclonal B-Cell Lymphocytosis (MBL).

Kami Maddocks-Christianson, MD, Curtis A. Hanson, MD, Greg Jenkins, Clive S. Zent, MD, Susan L. Slager, PhD, Timothy G. Call, MD, Deborah Bowen, Renee Tschumper, Diane F. Jelinek, PhD, Neil E. Kay, MD, Tait D. Shanafelt, MD

Blood (2007) 110 (11): 748.

https://doi.org/10.1182/blood.V110.11.748.748

Published: 2007

Journal Articles

Prior Treatment Relates More Strongly to Richter’s Transformation Than ZAP-70, CD38, IgV H Gene Mutation Status, and Cytogenetic Abnormalities: Findings of an Observational Cohort Study of 962 Patients with CLL.

Kami Maddocks-Christianson, Clive S. Zent, MD, Susan Slager, PhD, Susan Schwager, Megan Reinalda, Timothy G. Call, MD, Deborah Bowen, MD, James Hoyer, MD, Diane F. Jelinek, PhD, Neil E. Kay, MD, Tait D. Shanafelt, MD

Blood (2006) 108 (11): 2777.

https://doi.org/10.1182/blood.V108.11.2777.2777

Published: 2006

NARROW

The efficacy of ibrutinib in the treatment of Richter syndrome

The AKT Inhibitor MK2206 In Combination With Rituximab and Bendamustine Is Tolerable and Active In Relapsed Or Refractory Chronic Lymphocytic Leukemia: Results From a Phase 1 Study (NCCTG N1087 Alliance)

An Effective and Tolerable Chemoimmunotherapy Regimen For Relapsed/Refractory and Very-High Risk Chronic Lymphocytic Leukemia Combining Alemtuzumab With Pentostatin and Low Dose Rituximab

Long-term repair of T-cell synapse activity in a phase II trial of chemoimmunotherapy followed by lenalidomide consolidation in previously untreated chronic lymphocytic leukemia (CLL)

Allosteric Akt Inhibitor MK2206 Synergizes with Bendamustine in Promoting the Apoptosis of Chronic Lymphocytic Leukemia Cells and Selectively Targets B-Cell Receptor Mediated Cytokine Production

Clinical Utility of PET/CT Scanning in Patients with Chronic Lymphocytic Leukemia

Analysis of Stem Cell Transplant Referral in a Cohort of Newly Diagnosed Chronic Lymphocytic Leukemia Patients

The Prevalence of Serious Infectious Complications in a Cohort of Non-Referred Patients with Newly Diagnosed Chronic Lymphocytic Leukemia (CLL) Compared to Controls: Results of a Cohort Study

Lenalidomide Consolidation Appears to Prolong Time to Retreatment After First-Line Chemoimmunotherapy for Patients with Previously Untreated CLL,

Alemtuzumab Use and Survival After Reduced Intensity Allogeneic Stem Cell Transplantation in High-Risk Chronic Lymphocytic Leukemia (CLL),

Lendalidomide Consolidation After First-Line Chemoimmunotherapy for Patients with Previously Untreated CLL

Infectious Complications In a Prospective Cohort of Community Based Newly Diagnosed Patients with Chronic Lymphocytic Leukemia (CLL).

Treatment of Patients with Autoimmune Cytopenia and Progressive CLL Using Rituximab, Cyclophosphamide, Vincristine, and Prednisone (R-CVP).

Influence of Age at Diagnosis On Utility of Prognostic Testing in Patients with CLL.

B-Cell Count and Survival: Differentiating Chronic Lymphocytic Leukemia (CLL) from and Monoclonal B-Cell Lymphocytosis (MBL) Based on Clinical Outcome.

Treatment Free Survival of Patients with MBL and Early CLL: Follow-up of 405 Patients at Mayo Clinic.

The Physician-Patient Relationship Impacts Patient Quality of Life in Chronic Lymphocytic Leukemia: Results of an International Survey of 1482 Patients.

Molecular Prognostic Factors and Outcome among a Cohort of Patients with Monoclonal B-Cell Lymphocytosis (MBL).

Prior Treatment Relates More Strongly to Richter’s Transformation Than ZAP-70, CD38, IgV H Gene Mutation Status, and Cytogenetic Abnormalities: Findings of an Observational Cohort Study of 962 Patients with CLL.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only